© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Aardvark Therapeutics, Inc. Common Stock (AARD) shows an Average True Range (ATR) of 1.17 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 191.85K, indicating liquidity. These fundamental metrics provide insight into AARD's underlying financial health and market activity.
Aardvark Therapeutics, Inc. Common Stock (AARD) technical indicators as of December 23, 2025: the SMA 20 is 16.24%, SMA 50 at 24.13%, and SMA 200 at 30.62%. The RSI 14 value is 62.43, suggesting its current momentum. These technical analysis signals help assess AARD's price trends and potential future movements.
Aardvark Therapeutics, Inc. Common Stock (AARD) stock performance overview as of December 23, 2025: The 52-week high is $19.58 (currently -25.69% below), and the 52-week low is $4.88 (currently 198.16% above). Over the past year, AARD's performance is N/A, compared to the S&P 500's 10.56% change.
According to market data, Aardvark Therapeutics, Inc. Common Stock (AARD) stock's recent performance metrics show that over the last month, AARD is 39.1%, with a Year-to-Date (YTD) performance of N/A. Over the past year, the stock has seen a N/A change. These figures summarize AARD's price movements across various periods, reflecting its historical returns.
According to current financial data, AARD stock's P/E (TTM) ratio is -6.49, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for AARD, including P/S (N/A), P/B (2.59), and P/FCF (-7.02), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.